Citigroup Cuts Herbalife (NYSE:HLF) Price Target to $13.00

Herbalife (NYSE:HLFGet Free Report) had its target price reduced by equities researchers at Citigroup from $16.00 to $13.00 in a research report issued on Friday, Benzinga reports. The firm currently has a “buy” rating on the stock. Citigroup’s target price would suggest a potential upside of 93.16% from the company’s current price.

A number of other equities analysts also recently issued reports on the company. B. Riley increased their price target on Herbalife from $16.00 to $17.00 and gave the stock a “buy” rating in a research report on Thursday, August 1st. StockNews.com cut shares of Herbalife from a “buy” rating to a “hold” rating in a report on Tuesday, October 22nd. Finally, DA Davidson raised their target price on shares of Herbalife from $9.50 to $13.00 and gave the company a “neutral” rating in a research report on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $12.50.

Read Our Latest Stock Analysis on HLF

Herbalife Trading Down 2.6 %

Shares of HLF opened at $6.73 on Friday. The firm has a fifty day moving average price of $7.43 and a 200-day moving average price of $9.33. The firm has a market capitalization of $677.85 million, a P/E ratio of 8.21, a P/E/G ratio of 0.26 and a beta of 1.19. Herbalife has a 12-month low of $6.59 and a 12-month high of $15.66.

Herbalife (NYSE:HLFGet Free Report) last issued its earnings results on Wednesday, July 31st. The company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.43 by $0.11. Herbalife had a net margin of 1.63% and a negative return on equity of 18.69%. The business had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.33 billion. During the same period in the prior year, the firm earned $0.74 EPS. The company’s revenue for the quarter was down 2.5% compared to the same quarter last year. Analysts predict that Herbalife will post 1.34 earnings per share for the current year.

Insider Activity

In other news, Director Juan Miguel Mendoza bought 10,000 shares of the firm’s stock in a transaction that occurred on Monday, September 9th. The stock was bought at an average price of $7.11 per share, with a total value of $71,100.00. Following the completion of the transaction, the director now directly owns 120,000 shares of the company’s stock, valued at approximately $853,200. The trade was a 0.00 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.94% of the company’s stock.

Hedge Funds Weigh In On Herbalife

A number of large investors have recently made changes to their positions in the business. Russell Investments Group Ltd. grew its stake in Herbalife by 5,249.2% during the 1st quarter. Russell Investments Group Ltd. now owns 138,599 shares of the company’s stock worth $1,390,000 after buying an additional 136,008 shares during the last quarter. Capstone Investment Advisors LLC purchased a new stake in shares of Herbalife during the first quarter worth about $1,397,000. Price T Rowe Associates Inc. MD increased its holdings in shares of Herbalife by 4.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 82,287 shares of the company’s stock valued at $827,000 after acquiring an additional 3,647 shares in the last quarter. Baupost Group LLC MA raised its position in shares of Herbalife by 128.3% in the 2nd quarter. Baupost Group LLC MA now owns 5,124,526 shares of the company’s stock valued at $53,244,000 after purchasing an additional 2,879,603 shares during the last quarter. Finally, Maverick Capital Ltd. raised its position in shares of Herbalife by 409.4% in the 2nd quarter. Maverick Capital Ltd. now owns 127,887 shares of the company’s stock valued at $1,329,000 after purchasing an additional 102,784 shares during the last quarter.

About Herbalife

(Get Free Report)

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.

Featured Stories

Analyst Recommendations for Herbalife (NYSE:HLF)

Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.